Regulation - LGIC
Amendment of Regulation 682 under the Laboratory and Specimen Collection Centre Licensing Act and Regulation 552 under the Health Insurance Act by Addition of Severe Combined Immune Deficiency (SCID) under L022 Newborn Screening Test
Regulation Number(s):
682
552
552
Instrument Type:
Regulation - LGIC
Bill or Act:
Laboratory and Specimen Collection and Health Insurance Act
Summary of Decision:
Approved and became effective.
Further Information:
REGULATION 682
ONTARIO REGULATION 165/13
Laboratory and Specimen Collection Centre Licensing Act
Health Insurance Act
Regulation 552
Ontario Regulation 166/13
Proposal Number:
13-HLTC016
Posting Date:
Summary of Proposal:
In August 2012, the Newborn and Childhood Screening Subcommittee recommended Newborn Screening Ontario (NSO) add a 29th screening test for all newborns. The evidence based adjustment is to include Severe Combined Immune Deficiency (SCID) in Ontario's NSO program, and thus, amendment of Reg. 682 in conjunction with amendment of Reg. 552 is required.
The proposal affects quality of life, life expectancy, mortality and morbidity such that infants born with SCID who are not diagnosed and treated early will have a 100% mortality rate, usually before their first birthday. Infants who are treated before the onset of symptoms have an excellent prognosis.
The proposal affects quality of life, life expectancy, mortality and morbidity such that infants born with SCID who are not diagnosed and treated early will have a 100% mortality rate, usually before their first birthday. Infants who are treated before the onset of symptoms have an excellent prognosis.
Contact Address:
1075 Bay Street, Suite # 900, Toronto
Effective Date:
May 30, 2013
Decision:
Approved